Found 10 matching trials
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder PHASE2 This research study is being done to compare the effectiveness two drugs: a...
Show More Location
Cardiometabolic Research Unit
Learn More & Join Trial
Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal PHASE2 The goal of this randomized double-blind crossover study is to assess wheth...
Show More Location
Division of Nephrology, Hypertension & Renal Transplantation, University of Florida
Learn More & Join Trial
A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects PHASE3 This study will examine comparative bioavailability of single dose of a fix...
Show More Location
Sarfez Pharmaceuticals
Learn More & Join Trial
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease PHASE3 A study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Co...
Show More Location
Sarfez Pharmaceuticals, Inc.
Learn More & Join Trial
Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects PHASE3 This study examines the bioavailability and bioequivalence of single dose o...
Show More Location
Sarfez Pharmaceuticals
Learn More & Join Trial
Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone PHASE3 To study intrasubject variability and steady-state pharmacokinetics of mult...
Show More Location
Sarfez Pharmaceuticals
Learn More & Join Trial
A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs PHASE4 This is a randomized double-blind crossover study of the patients with stab...
Show More Location
Future Life Clinical Trials
Learn More & Join Trial
Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects PHASE1 The study will evaluate the within-subject variability of 20mg ER torsemide...
Show More Location
I.E.C. Consultants
Learn More & Join Trial
Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide PHASE1 To compare the effects of 40 mg once-daily Torsemide ER to 40 mg twice dail...
Show More Location
Syngene International
Learn More & Join Trial
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure PHASE4 The primary objective of this study is to learn whether a morning dose of e...
Show More Location
Future Life Clinical Trials
Learn More & Join Trial